MKNK2 antibody
Principal name
MKNK2 antibody
Alternative names for MKNK2 antibody
GPRK7, MNK2, MAP kinase-interacting serine/threonine-protein kinase 2
Ncbi ID
9606, NP_951009, NM_017572, NP_951009.1, NP_060042, NP_060042.2, NP_067437.1, NM_021462, NM_001011985
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Paraffin Sections (P)
Background of MKNK2 antibody
MAP kinase-interacting kinase 1 (Mnk1) and Mnk2, members of the Ser/Thr protein kinase family, bind tightly to the growth factor-regulated MAP kinases, Erk1 and Erk2. Erk and p38 phosphorylate MNK1 and Mnk2, which stimulates their in vitro kinase activity toward a substrate, eukaryotic initiation factor-4E (eIF-4E). Overexpression of Mnk2 results in increased phosphorylation of endogenous eIF-4E, showing that it can act as an eIF-4E kinase in vivo. Mnk2 may play a role in the response to environmental stress and cytokines. This ubiquitiously expressed protein appears to regulate transcription by phosphorylating eIF-4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap. Expression of active mutants of MNK1 and MNK2 in 293 cells diminishes cap-dependent translation relative to cap-independent translation in a transient reporter assay. Human Mnk2 is homologous to murine Mnk2 (approximately 94% identical) and human Mnk1 (71% identical). In vitro phosphorylation studies show that Mnk2 is a significantly better substrate than Mnk1 for extracellular signal-regulated kinase 2 (Erk2), p38MAPKalpha, and p38MAPKbeta. Mnk2 has also been shown to interact with the C-terminal regions of eIF-4G1 and eIF-4G2.
General readings
Wang,P., (2006) Sci. China, C, Life Sci. 49 (3), 265-273

















- Quick-Filters:
- Cited (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA313959 | MKNK2 antibody |
||||||
| Rabbit polyclonal anti-MNK2 antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP13616PU-N | MKNK2 (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| AP13794PU-N | MKNK2 (C-term) antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP316704 | MKNK2 (transcript variant 2) |
||||
| Recombinant protein of human MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 2 | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP760279 | MKNK2 (full length, N-term HIS tag, transcript variant 1) |
||||
| Recombinant protein of human MAP kinase interacting serine/threonine kinase 2 (MKNK2), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug | |||||
![]() |
Human | > 80 % Preparation: . Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
E. coli |
50 µg /
€205.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY413712 | MKNK2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
Published recently! |
||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR204301L2V | Lenti ORF particles, Mknk2 (GFP-tagged ORF) - Rat MAP kinase-interacting serine/threonine kinase 2 (Mknk2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,120.00
|
|
| OriGene Technologies, Inc. | ||
| RR204301L1V | Lenti ORF particles, Mknk2 (Myc-DDK-tagged ORF) - Rat MAP kinase-interacting serine/threonine kinase 2 (Mknk2), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,010.00
|
|
| OriGene Technologies, Inc. | ||












